prucalopride and Endocrine-Gland-Neoplasms

prucalopride has been researched along with Endocrine-Gland-Neoplasms* in 1 studies

Reviews

1 review(s) available for prucalopride and Endocrine-Gland-Neoplasms

Article	Year
Genotoxicity and carcinogenicity risk assessment of prucalopride, a selective 5-hydroxytryptamine 4 receptor agonist. Regulatory toxicology and pharmacology : RTP, 2020, Volume: 112 Prucalopride, a high affinity, selective serotonin type 4 (5-HT Topics: Animals; Benzofurans; Endocrine Gland Neoplasms; Humans; Liver Neoplasms; Receptors, Serotonin, 5-HT4; Risk Assessment; Serotonin 5-HT4 Receptor Agonists	2020

Article

Year

Genotoxicity and carcinogenicity risk assessment of prucalopride, a selective 5-hydroxytryptamine 4 receptor agonist.

Regulatory toxicology and pharmacology : RTP, 2020, Volume: 112

Prucalopride, a high affinity, selective serotonin type 4 (5-HT

Topics: Animals; Benzofurans; Endocrine Gland Neoplasms; Humans; Liver Neoplasms; Receptors, Serotonin, 5-HT4; Risk Assessment; Serotonin 5-HT4 Receptor Agonists

2020